Retatrutide has emerged as a new medication in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating https://blancheacce350360.gynoblog.com/35275082/tirzepatide-a-promising-new-treatment-for-obesity